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Abstract Tyrosine-rich acidic matrix protein (TRAMP; 22 kDa extracellular matrix protein; dermatopontin) is a protein that co-purifies with lysyl 
oxidase and with dermatan sulphate proteoglycans, with possible functions in cell-matrix interactions and matrix ssembly. Using a rabbit polyclonal 
antiserum raised against porcine TRAMP, which cross-reacts with both the human and murine forms of the protein, we show by immunoblotting 
that TRAMP has a widespread tissue distribution, including skin, skeletal muscle, heart, lung, kidney, cartilage and bone. In cultures of human skin 
fibroblasts, TRAMP incorporates both [35S]sulphate nd [3H]tyrosine and is secreted into the medium, as shown by immunoprecipitation. Amino 
acid analysis of immunoprecipitated TRAMP demonstrates that m ny of the tyrosine residues in TRAMP are sulphated. 
Key words." Extracellular matrix; Tyrosine sulphation; TRAMP 
1. Introduction 
The extracellular matrix plays fundamental roles in morpho- 
genesis, cell differentiation, cell migration, metastasis, connec- 
tive tissue disease and repair [1-3]. In vertebrates, the matrix 
consists of collagens [4,5], proteoglycans [6], and other glycosyl- 
ated and non-glycosylated proteins [1]. A common feature of 
many matrix macromolecules is their ability to interact with 
other components ofthe matrix during the formation of various 
supra-molecular aggregates, e.g. collagen fibrils. In the last few 
years, several non-collagenous matrix components have been 
shown to control the assembly of fibril-forming collagens into 
fibrils [7]. These include the small, leucine-rich proteoglycans 
decorin, fibromodulin and lumican [5], which delay fibril for- 
mation and control fibril diameter [8-12]. 
Collagen fibrils are stabilised by inter- and intra-molecular 
covalent cross-links, which form spontaneously after oxidative 
de-amination of specific lysine (or hydroxylysine) residues by 
the enzyme lysyl oxidase [13]. During the course of purifying 
lysyl oxidase (32 kDa) from porcine skin, we recently character- 
ised a protein (22 kDa) that co-purifies with the enzyme [14]. 
This new protein is acidic and rich in tyrosine, and we refer to 
it as TRAMP (tyrosine-rich acidic matrix protein). TRAMP is 
the same as a protein previously isolated from bovine skin, 
which co-purifies with dermatan sulphate proteoglycans [15]. 
The bovine form of TRAMP has cell adhesion activity, which 
is blocked by dermatan sulphate proteoglycans [16], hence the 
protein is thought to be involved in cell-matrix interactions in
vivo. The human equivalent ofTRAMP, called dermatopontin, 
has recently been identified at the cDNA level [17]. Comparison 
of the cDNA derived sequence with the complete protein se- 
quence of the mature protein ([15]; Cronshaw et al., unpub- 
lished data) indicates that TRAMP is synthesised with an 18 
residue, N-terminal signal sequence, but without a propeptide 
region. Recently we have found an additional possible function 
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of TRAMP, namely to accelerate he assembly of collagen into 
fibrils [7]. TRAMP appears then to be a multi-functional pro- 
tein of the extracellular matrix. Here, using a polyclonal antis- 
erum raised against porcine TRAMP, we show that TRAMP 
has a widespread tissue distribution. Furthermore, TRAMP is 
synthesised and secreted by human fibroblasts in culture, and 
the protein is tyrosine sulphated. 
2. Materials and methods 
2.1. Materials 
Reagents for cell culture were obtained from Gibco, Paisley, 
Strathclyde, UK. L-[3,5-3H]Tyrosine (specific activity 1.81 TBq/mmol) 
and [35S]sulphate (carrier free) were purchased from Amersham Inter- 
national plc, Amersham, Bucks., UK, and [14C]formaldehyde (specific 
activity 1.5 GBq/mmol) was from ICN Biomedicals Ltd., Thame, 
Oxfordshire, UK. Killed Staphylococcus A. bacteria (Pansorbin) were 
obtained from Calbiochem Novabiochem Ltd., Nottingham, UK. 
Donkey anti-rabbit IgG was obtained from the Scottish Antibody Pro- 
duction Unit, Law Hospital, Carluke, Lanarkshire, UK. Other reagents 
were from BDH/Merck, Poole, Dorset, UK. 
2.2. Preparation of polyclonal antiserum 
TRAMP was purified from the skins of stillborn piglets, by DEAE 
ion-exchange chromatography and selective interaction with Sephacryl 
S-400, followed by preparative reverse-phase chromatography on a 
Pharmacia ProRPC HR5/2 column, as described [14]. Polyclonal antis- 
erum was raised against TRAMP by subcutaneous injection of New 
Zealand White rabbits with an initialdose of 200/.tg TRAMP emulsi- 
fied in a 1 : 1 mixture of complete Freund's adjuvant, followed by a I00 
/~g boost (in incomplete Fr und's adjuvant) and then four further 
boosts injected every 6 weeks. 
2.3. Tissue extraction and Western blotting 
Tissues were dissected (in phosphate-buffered saline containing 
1 mM phenylmethyl-sulphonylfluoride (PMSF)) from stillborn piglets 
and from 3- to 4-week-old c57 black mice. Human foreskin (Depart- 
ment of Dermatology) and chicken skin (commercial broiler) were also 
analysed. Tissues were homogenised in glass homogenisers (most tis- 
sues) or pulverised, after freezing in liquid N2, in a stainless-steel bomb 
(bone, cartilage, tendon). Extraction was at 4°C, with continuous rota- 
tion for 24-72 h, in 6 M urea, 10 mM sodium phosphate, pH 7.8, 
con-taining 1 mM PMSF, using approximately 2 ml buffer per g of 
tissue (wet weight). Homogenates were centrifuged in a Beckman TL- 
100 centrifuge (66,000 × g, 10 min) and supernatants were collected for 
determination f protein concentration by absorbance at 280 nm or 
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using the bicinchoninic acid assay (Pierce) at 60°C. Approximately 100 
#g of each extract was then analysed, after reduction with 2-mercap- 
toethanol, by discontinuous SDS-PAGE [18] with 12% acrylamide, 
0.32% bis-acrylamide in the separating el. 
Gels were electro-blotted on to cellulose nitrate (Schleicher and 
Schuell) using a Bio-Rad blotting tank [19]. After identification of 
protein bands by staining with Ponceau S [20], the nitrocellulose was 
blocked with 5% (w/v) dried milk in TBS-T (137 mM NaC1, 20 mM 
Tris-HC1, pH 7.5, 0.2% Tween-20) then incubated in the rabbit, poly- 
clonal antiserum (or pre-immune serum) diluted 1,000- to 10,000-fold. 
After repeated washing to remove unbound proteins, bound antibodies 
were detected by enhanced chemiluminescence (Amersham) using 
horseradish peroxidase-coupled donkey anti-rabbit IgG, diluted 
1 : 5,000, and either Kodak X-Omat AR or Amersham Hyperfilm MP 
film. 
To identify radiolabelled tyrosine and sutphotyrosine, excess unla- 
belled porcine TRAMP was added to the immunoprecipitates and, after 
SDS-PAGE, proteins were electro-blotted (in 10 mM CAPS, 10% meth- 
anol, pH 11) on to ProBlott membrane [23] using a semi-dry blotting 
unit. TRAMP bands were identified by Coomassie blue staining (0.1% 
(w/v) in 50% methanol), cut out, de-stained (10% acetic acid, 50% 
methanol) and dried. As the ester bond of sulphotyrosine is acid labile 
but resistant to alkaline hydrolysis [22], radiolabelled TRAMP bands 
on ProBlott membrane were hydrolysed in 0.2 M Ba(OH)2 at 110°C for 
22 h, followed by neutralisation a d precipitation ofBa(SO4)2 with 1 M 
H2SO4. After removal of the precipitate by centrifugation (15,600 × g, 
5 min) supernatants were applied to the amino acid analyser. 
2.4. Cell culture 
Human foreskin fibroblasts (passage 7) were a gift from Dr. G.W. 
Priestley, Department of Dermatology, University of Edinburgh. The 
cells were cultured in 75 cm 2 flasks in Dulbecco's modified Eagles 
medium (DMEM) containing 10% (v/v) foetal calf serum, 100 1U/ml 
penicillin and 100/.tg/ml streptomycin, at37°C in an atmosphere of 5% 
CO2. At confluency, the medium was replaced, without washing, by 
serum-free minimum essential medium (MEM; 10 ml per 75 cm 2 flask) 
prepared (from a Gibco Select-Amine kit) either without yrosine, or 
without sulphate (MgSO 4 and CaSO 4 replaced by MgCI2 and CaCI2), 
and supplemented with the corresponding radiolabel, either L-[3,5- 
3H]tyrosine (50 #Ci/ml) or [35S]sulphate (100 #Ci/ml). Cells were incu- 
bated in the presence of radiolabel for 20-24 h. 
Following incubation, the culture medium was collected and placed 
on ice, proteinase inhibitors were added (from a l0 x stock in 0.5 M 
Tris-HCl, pH 7.5) to final concentrations of 20 mM EDTA, l0 mM 
N-ethylmaleimide (NEM), 1 mM phenylmethylsulphonylfluoride 
(PMSF), and the medium was centrifuged at 3,000 x g for l0 min, then 
stored at -20°C. The cell layers were lysed in 1.5 ml (per flask) of lysis 
buffer (1% Nonidet NP-40, 0.15 M NaCl, 20 mM EDTA, l 0 mM NEM, 
1 mM PMSF, 50 mM Tris-HC1, pH 7.5) at 0°C for 30 min. Lysates were 
collected using a cell scraper, centrifuged (10,000 x g for l0 min) and 
the supernatants collected and stored. 
2.5. Immunoprecipitation 
Proteins were immunoprecipitated from culture medium or f om cell 
lysates using killed Staphylococcus A. bacteria that were pre-loaded [20] 
either with pre-immune serum (PIS) or with anti-TRAMP antiserum 
(ATS). Briefly, the Staph. A. bacteria were washed and resuspended in 
buffer A (9 parts MEM : 1 part 500 mM Tris-HCl, 200 mM EDTA, pH 
7.5) to a final concentration of 10% (w/v). For pre-loading, Staph. A. 
bacteria were incubated for 30 min at 4°C with a 1/10th vol. of ATS 
or PIS, followed by repeated centrifigation and resuspension i  buffer 
A, to a final concentration of 20% (w/v). To the cell culture medium 
and cell lysates, bovine serum albumin was added to a final concentra- 
tion of 100/zg/ml. The PIS-loaded Staph. A. bacteria were then added 
to the medium (volume ratio 1:20), or to the lysate (1:2), followed by 
incubation with gentle agitation for 2 h at 4°C. Proteins bound non- 
specifically to the PIS-loaded Staph. A. bacteria were then removed by 
centrifugation (10,000 x g, 1 min) and the supematant was retained for 
immunopr~'cipitation with ATS-loaded Staph. A. bacteria. Cell pellets 
(PIS and ATS precipitates) were extracted in SDS-PAGE sample buffer 
(2% (w/v) SDS, 0.125 M Tris-HC1, pH 6.8, 10% (v/v) glycerol, 3% (v/v) 
2-mercaptoethaaol, 0.005% (w/v) Bromophenol blue) for 3 min at 
100°C, followed by centrifugation (10,000 × g, 1 min) and analysis of 
supernatants by SDS-PAGE [18]. 
2.6. Identification fsulphotyrosine 
Sulphotyrosine was synthesised by reaction of L-tyrosine with con- 
centrated sulphuric acid [2!]. Briefly, 5 g tyrosine and 10 ml concen- 
trated sulphuric acid (both pre-cooled to -20°C) were mixed and 
stirred rapidly on ice for 10 min, then neutralised with Ba(OH)2, and 
the sulphotyrosine separated fromunreacted tyrosine o  aBio-Rad AG 
50W-X8 column [22]. The elution position of the phenylthiocarbamyl 
(PTC) derivative of sulphotyrosine was determined on an Applied Bio- 
systems 420A amino acid analyser [14] after derivatisation with phenyli- 
sothiocyanate. PTC-sulphotyrosine eluted between PTC-proline and 
phenylthiourea. 
2.7. Other procedures 
Purified porcine TRAMP and molecular weight standards (Pharma- 
cia) were radiolabelled by reductive alkylation with ['4C]formaldehyde 
and cyanoborohydride [24] using Amicon C-10 microconcentrators for 
buffer exchange and concentration. Radiolabelled proteins separated 
by SDS-PAGE were detected by fluorography [25] using Kodak X- 
Omat AR film. 
3.  Resu l ts  
3.1. Tissue distribution of TRAMP 
By Western blotting, the rabbit  antiserum raised against por- 
cine TRAMP recognised a single band at the migration position 
of purified TRAMP in urea extracts of porcine, murine and 
human skin (not shown). No cross-reactivity was seen against 
extracts of chicken skin, and the pre- immune serum control was 
negative (not shown). 
Extracts from a number  of porcine and murine tissues were 
examined for the presence of TRAMP using the polyclonal 
antiserum. The results for porcine tissues (Fig. 1) showed 
TRAMP to be present in extracts of several tissues, including 
skin, skeletal muscle, heart, lung, articular cartilage, long bone, 
calvaria, with smaller amounts in kidney, and essentially none 
in brain, liver and spleen. The distr ibution of TRAMP in ex- 
tracts of murine tissues was similar, and no reaction was seen 
with pre- immune serum (not shown). 
3.2. Biosynthesis and tyrosine sulphation of TRAMP 
To examine the biosynthesis of TRAMP in cell culture, 
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Fig. 1. Tissue distribution of TRAMP. Purified porcine TRAMP and 
extracts of porcine tissues in 6 M urea, l0 mM sodium phosphate, pH 
7.8, 1 mM PMSF were analysed by discontinuous SDS-PAGE (12% 
acrylamide, 0.32% bisacrylamide in the separating gel), electro-blotted 
to nitrocellulose and probed with a 1 : 1,000 dilution of the polyclonal 
antiserum. Bound antibodies were detected by enhanced chemilumines- 
cence using peroxidase-coupled donkey anti-rabbit IgG. Lane l, puri- 
fied porcine TRAMP (0.5/zg); lanes 2-12, 100 #g protein per lane. 
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Fig. 2. Immunoprecipitation of (a) [3H]tyrosine labelled TRAMP and 
(b) [35S]sulphate-labelled TRAMP from human fibroblast cultures. 
Lane 1, 14C-labelled molecular mass markers; lane 2, 14C-labelled 
TRAMP; lane 3, immunoprecipitate from culture medium, anti- 
TRAMP antiserum; lane 4, immunoprecipitate from c ll lysate, anti- 
TRAMP antiserum; lane 5, pre-cleared precipitate from culture 
medium, pre-immune serum; lane 6, pre-cleared precipitate from cell 
lysate, pre-immune serum. 
human fibroblasts were incubated in the presence of L-[3,5- 
5H]tyrosine, and proteins in both medium and cell layer were 
immunoprecipitated with the polyclonal ntiserum. Analysis by 
SDS-PAGE and fluorography (Fig. 2a) showed that the [3H]ty- 
rosine was incorporated into a protein that was specifically 
precipitated by the anti-TRAMP antiserum. The protein mi- 
grated at the same position as '4C-labelled, purified porcine 
TRAMP, and was present mainly in the culture medium. 
Higher molecular mass proteins were also precipitated from the 
culture medium, but these were bound non-specifically, as 
shown by the pre-immune serum control. From the cell lysates, 
a protein of apparent molecular mass omewhat less than the 
[~4C]TRAMP standard was immunoprecipitated. 
Fibroblasts were also cultured in the presence of 
[3~S]sulphate. As with the [3H]tyrosine label, a 35S-labelled 
protein that co-migratedwith [IaC]TRAMP was specifically pre- 
cipitated with the anti-TRAMP antiserum (Fig. 2b) and this 
protein was present mainly in the culture medium. Higher mo- 
lecular mass bands were also present but these were precip- 
itated non-specifically. The aSS-labelled band that co-migrated 
with [14C]TRAMP was also clearly visible after SDS-PAGE and 
fluorography of crude, concentrated culture medium (not 
shown). 
Previous work has indicated that TRAMP is not a glycopro- 
tein [15], and the effect of sulphatase treatment or mild acid 
hydrolysis on Alcian blue staining indicated that TRAMP con- 
tained sulphotyrosine [14]. To examine this possibility, im- 
munoprecipitated TRAMP from the human fibroblast culture 
medium was separated by SDS-PAGE, then transferred to 
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ProBlott and subjected to alkaline hydrolysis. When separated 
by reverse-phase chromatography on the amino acid analyser, 
the major peak in hydrolysates of the 35S-labelled TRAMP was 
at the elution position of the PTC-sulphotyrosine standard 
(Fig. 3). Hydrolysates of the [3H]tyrosine-labelled TRAMP 
gave two peaks, at the elution positions of PTC-tyrosine and 
PTC-sulphotyrosine, in approximately equal proportions. 
4. Discussion 
The results obtained by Western blotting show that TRAMP 
has a widespread tissue distribution in both porcine and murine 
tissues. The protein is most abundant in tissues that are rela- 
tively rich in extracellular matrix, such as skin, lung, cartilage 
and bone, though significant amounts are present in skeletal 
muscle, heart and kidney. The results on the protein distribu- 
tion of TRAMP are in good agreement with the Northern blot 
analysis [17] on the human form of TRAMP, dermatopontin. 
The cell culture work confirms that TRAMP is a secreted 
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Fig. 3. Amino acid analysis of radiolabelled TRAMP in alkaline hyroly- 
sates. (a) Separation of PTC-sulphotyrosine and PTC-tyrosine stan- 
dards by reverse-phase chromatography on the PTC C-18 column of 
the amino acid analyser. (b, c) Separation of radiolabelled amino acids 
after alkaline hydrolysis of immunoprecipitated TRAMP after transfer 
to ProBlott membranes. Counts were for 40 min with (b) [3SS]suiphate- 
labelled TRAMP and (c) [3H]tyrosine-labelled TRAMP. The column 
(5/zm particle size; 2.1 x 220 mm) was pre-equilibratexi with 3% (v/v) 
acetonitrile, 50 mM sodium acetate, pH 5.4, and eluted with a linear 
gradient from 2% to 64% buffer B (70% acetonitrile, 32 mM sodium 
acetate, pH 6.1) over 18.8 min. 
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protein. Unlike the observations of Superti-Furga etal. [17], we 
found that TRAMP was labelled with [35S]sulphate during bio- 
synthesis. Northern blot analysis of dermatopontin [17] demon- 
strated the presence of two mRNA species, of 1.0 and 2.2 kb, 
with the possible intrepretation that there may be different, 
alternatively spliced forms of TRAMP. We found no evidence 
for any additional forms of TRAMP that could be labelled with 
[3H]tyrosine or [35S]sulphate and immunoprecipitated with the 
polyclonal antiserum. With the [3H]tyrosine-labelled cultures, 
immunoprecipitates from the cell lysates revealed a protein that 
migrated somewhat f ster than the [14C]TRAMP standard or 
the [3H]TRAMP from the culture medium. It is likely that this 
is an intracellular form of TRAMP, prior to tyrosine sulpha- 
tion. 
Studies by Lewandowska et al. [16] indicate that the bovine 
form of TRAMP interacts with dermatan sulphate proteogly- 
cans. We found no evidence in the immunoprecipitates for a 
complex between TRAMP and sulphated proteoglycans, asthe 
high molecular mass 35S-labelled material in the stacking gel 
and also at the top of the separating gel, in the region expected 
for decorin, biglycan and other proteoglycans [17], was also 
present in the pre-immune serum controls (Fig. 2). 
We have established that TRAMP contains ulphotyrosine 
residues, and therefore TRAMP can be included in the list of 
other extracellular matrix proteins (e.g. procollagen III [26], 
procollagen V [27], fibromodulin [28], fibronectin [29], vitro- 
nectin [30], bone sialoprotein [31]) that are known to be post- 
translationally modified in this way. Tyrosine sulphation has 
been shown to be important in the interaction properties of 
several secreted proteins [29,32-35]. Further studies are re- 
quired to determine if the known interactions of TRAMP, with 
collagen in fibril assembly [7] and with a putative cell surface 
receptor in cell adhesion [16], are also influenced by tyrosine 
sulphation. 
The widespread tissue distribution of TRAMP suggests that 
it may have a general function in the extracellular matrix. We 
note that bovine [15], human [17] and porcine (Cronshaw et al., 
unpublished observations) TRAMP contain the sequence Asn- 
Tyr-Asp, which conforms to the proposed consensus sequence 
(Asn-Tyr-Asp/Glu) for the formation of topaquinone in cop- 
per-dependent amine oxidases [36-38]. This suggests the possi- 
bility that TRAMP may itself have amine oxidase activity, in 
addition to that of lysyl oxidase. Experiments to test his hy- 
pothesis are in progress. 
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